GAAP Financial Statements
INTEGRATED BIOPHARMA INC (INBP)
3 quarters · 1 annual periods · CIK 0001016504
Quarterly (3)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 10-Q | $12.7M | $1.0M | $163.0K | $123.0K | $0.00 | $0.00 | $25.5M | $4.7M |
| Q3 FY2025 | 10-Q | $10.2M | $1.5M | $739.0K | — | $0.02 | $0.02 | $19.9M | $3.0M |
| Q2 FY2025 | 10-Q | $2.4M | $374.0K | $202.0K | $116.0K | $0.00 | $0.00 | $25.7M | $2.5M |
Annual (1)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| FY FY2025 | 10-K | $54.4M | $4.8M | $2.0M | $808.0K | $0.03 | $0.03 | $20.3M | $3.6M |
Source: SEC EDGAR XBRL filings. Per-period figures are pulled from the original 10-Q / 10-K / 20-F submissions. Balance-sheet items (Assets, Cash, Equity) are point-in-time at period end.